Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease.

Zhang Z, Wang X, Wang S.

In Vitro Cell Dev Biol Anim. 2008 May-Jun;44(5-6):169-77. doi: 10.1007/s11626-008-9093-1. Epub 2008 Apr 10.

PMID:
18401666
2.
3.

Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.

Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S.

Cell Biol Int. 2008 Apr;32(4):384-93. doi: 10.1016/j.cellbi.2007.12.007. Epub 2008 Jan 9.

PMID:
18262807
4.
5.

[Comparative study of human fetal and adult bone marrow derived mesenchymal stem cells].

Hu Y, Ma L, Ma G, Jiang X, Zhao C.

Zhonghua Xue Ye Xue Za Zhi. 2002 Dec;23(12):645-8. Chinese.

PMID:
12667349
6.

Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.

Bernardo ME, Emons JA, Karperien M, Nauta AJ, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold GA, Vukicevic S, Locatelli F, Fibbe WE.

Connect Tissue Res. 2007;48(3):132-40.

PMID:
17522996
7.

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.

In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH.

Stem Cells. 2004;22(7):1338-45.

8.

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.

Ann Rheum Dis. 2008 Apr;67(4):443-9. Epub 2007 May 25.

PMID:
17526552
9.

Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.

Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX.

Chin Med J (Engl). 2007 May 5;120(9):771-6.

PMID:
17531117
10.

Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.

Jootar S, Pornprasertsud N, Petvises S, Rerkamnuaychoke B, Disthabanchong S, Pakakasama S, Ungkanont A, Hongeng S.

Leuk Res. 2006 Dec;30(12):1493-8. Epub 2006 Jul 12.

PMID:
16839603
11.

[Biological characteristics of mesenchymal stem cells from bone marrow of patients with aplastic anemia].

Chen J, Wang Q, Shi YT, Zhou XF, Xu XJ, Liu A.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):832-8. Chinese.

PMID:
16277853
12.

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM.

Transl Res. 2010 Feb;155(2):62-70. doi: 10.1016/j.trsl.2009.07.006. Epub 2009 Aug 6.

PMID:
20129486
13.

Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.

Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC, Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F, Christofis A, Amaral VF, Brofman PS, Goldenberg S, Nakao LS, Correa A.

Exp Biol Med (Maywood). 2008 Jul;233(7):901-13. doi: 10.3181/0712-RM-356. Epub 2008 Apr 29.

PMID:
18445775
14.

[Biological properties of mesenchymal stem cells derived from bone marrow of patients with multiple myeloma].

Zhu BD, Ren J, Wang XY, Li X, Nie J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1138-42. Chinese.

PMID:
17204180
15.

Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.

Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, Offen D.

J Mol Neurosci. 2009 Sep;39(1-2):199-210. doi: 10.1007/s12031-008-9166-3. Epub 2009 Jan 6.

PMID:
19127447
16.

Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation.

Keyser KA, Beagles KE, Kiem HP.

Cell Transplant. 2007;16(5):555-62.

PMID:
17708345
17.

Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.

Zhao ZG, Li WM, Chen ZC, You Y, Zou P.

Immunol Invest. 2008;37(7):726-39. doi: 10.1080/08820130802349940.

PMID:
18821219
18.

[Effect of human bone marrow mesenchymal stem cell on allogeneic T lymphocyte phenotype in vitro].

Ning HM, Jin JG, Hu JW, Feng K, Chen H.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):43-9. Chinese.

PMID:
15748434
19.

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A.

Rheumatology (Oxford). 2007 Mar;46(3):403-8. Epub 2006 Aug 18.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk